ANVISA Approved

DPP® SARS-CoV-2
IgM/IgG System

Serology Rapid Test for Fingerstick Blood REQUEST MORE INFORMATION

REQUEST MORE INFORMATION
DPP® SARS-CoV-2 IgM/IgG Product Image

An ANVISA Approved rapid test for the detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in capillary “fingerstick” whole blood, venous whole blood, serum and plasma samples. This post vaccination test detects antibodies to the Receptor Binding Domain (RBD).

Innovative

  • Two Results: Simultaneous and separate detection of IgM and IgG antibodies to SARS-CoV-2
  • Our readers provide results in seconds, are simple to use, handheld, and portable making them well-suited for decentralized testing

Efficient

  • Small sample size: Only 15 μL of fingerstick blood
  • Fast: Get results in 15 minutes
  • Room temperature storage (2°C to 30°C; 36°F to 86°F)

Accurate & Reliable

  • Built-in procedural control
  • Tests are manufactured in the USA
  • Objective results give you confidence in interpretation

est for SARS-CoV-2 in 3 Easy Steps with DPP® SARS-CoV-2 IgM/IgG

Chembio SARS-CoV-2 IgM/IgG System 3 East Steps

Product Information

Information Type Product Detail
Method Dual Path Platform
Sample Fingerstick blood, venous whole blood, serum, plasma
Time to Results 15 Minutes
Storage Conditions 2°C to 30°C (36°F to 86°F)

Products Downloads & Links

Please fill out the form below.